Doctor profile · Federal record
Dr. AKINTUNDE AKINLEYE, M.D, MSC
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · DANVILLE, VA
- NPI 1881990505
- Accepts Medicare
- 23 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
125 EXECUTIVE DR, SUITE J
DANVILLE, VA 245414155
(434) 793-0044
Credentials & registration
- NPI registered
- January 2011 — 15 yrs on file
- Profile last updated
- November 6, 2015
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Virginia #0101259156 · New York #274145
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881990505. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,509
Distinct HCPCS
8
Medicare allowed
$138,624
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,014 | 364 | $95 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 332 | 169 | $65 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 51 | 51 | $131 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 28 | 28 | $178 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 21 | $164 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 22 | 20 | $141 | |
38222 |
Biopsy and aspiration of bone marrow sample for diagnosis | 19 | 16 | $74 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 19 | 14 | $35 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 188. This provider delivers 8.0× the peer median.Open Payments
Industry payments received
All-time total
$1,979
Transactions
49
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,050.94 | |
| AstraZeneca Pharmaceuticals LP | 5 | $110.10 | |
| PFIZER INC. | 5 | $91.03 | |
| SERVIER PHARMACEUTICALS LLC | 3 | $74.74 | |
| Adaptive Biotechnologies Corporation | 3 | $72.79 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $66.43 | |
| Janssen Biotech, Inc. | 3 | $60.06 | |
| BeiGene USA, Inc. | 3 | $54.26 | |
| GlaxoSmithKline, LLC. | 2 | $43.67 | |
| Coherus Biosciences Inc. | 2 | $40.38 | |
| Stemline Therapeutics Inc. | 1 | $29.61 | |
| Daiichi Sankyo Inc. | 1 | $29.22 | |
| EMD Serono, Inc. | 1 | $28.66 | |
| Celgene Corporation | 1 | $24.90 | |
| Merck Sharp & Dohme LLC | 1 | $22.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,374
Patients
464
Total drug cost
$2,277,941
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 295 | 89 | $16,834 |
| Acyclovir | Generic | 144 | 38 | $3,001 |
| Eliquis (Apixaban) | Brand | 105 | 27 | $112,226 |
| Alendronate Sodium | Generic | 98 | 29 | $832 |
| Hydroxyurea | Generic | 96 | 29 | $3,094 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 86 | 29 | $2,608 |
| Gabapentin | Generic | 78 | 18 | $1,152 |
| Anastrozole | Generic | 75 | 25 | $2,226 |
| Ondansetron Odt (Ondansetron) | Brand | 70 | 53 | $4,244 |
| Revlimid (Lenalidomide) | Brand | 60 | 12 | $1,252,566 |